Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against chikungunya virus in vero cells
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The resurgence of Chikungunya virus (CHIKV) in the form of unprecedented and explosive epidemics in India and the Indian Ocean islands after a gap of 32 years is a major public health concern. Currently, there is no specific therapy available to treat CHIKV infection. In the present study, the in vitro prophylactic and therapeutic effects of chloroquine on CHIKV replication in Vero cells were investigated. Inhibitory effects were observed when chloroquine was administered pre‐infection, post‐infection, and concurrent with infection, suggesting that chloroquine has prophylactic and therapeutic potential. The inhibitory effects were confirmed by performing a plaque reduction neutralization test (PRNT), real‐time reverse transcriptase (RT)‐PCR analysis of viral RNA levels, and cell viability assays. Chloroquine diminished CHIKV infection in a dose‐dependent manner, with an effective concentration range of 5–20 µM. Concurrent addition of drug with virus, or treatment of cells prior to infection drastically reduced virus infectivity and viral genome copy number by ≥99.99%. The maximum inhibitory effect of chloroquine was observed within 1–3 hr post‐infection (hpi), and treatment was ineffective once the virus successfully passed through the early stages of infection. The mechanism of inhibition of virus activity by chloroquine involved impaired endosomal‐mediated virus entry during early stages of virus replication, most likely through the prevention of endocytosis and/or endosomal acidification, based on a comparative evaluation using ammonium chloride, a known lysosomotropic agent. J. Med. Virol. 82: 817–824, 2010. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,811
Infection with chikungunya virus in Italy: an outbreak in a temperate region
Rezza, G., Nicoletti, L., Angelini, R., Romi, R., Finarelli, A., Panning, M., Cordioli, P., Fortuna, C., Boros, S., Magurano, F., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61779-6 · Cited by 1,527 · cited 1×
“Recent cases of CHIKV infection in Europe and Italy have occurred as a result of travel to and from infected areas [Rezza et al., 2007].”
BackgroundEffects of chloroquine on viral infections: an old drug against today's diseases
Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,268 · cited 2×
“Increasingly, chloroquine is being applied to the clinical management of viral diseases [Savarino et al., 2003 [Savarino et al., , 2006 .”
BackgroundGenome Microevolution of Chikungunya Viruses Causing the Indian Ocean Outbreak
Schuffenecker, I., Iteman, I., Michault, A., Murri, S., Frangeul, L., Vaney, M.-C., Lavenir, R., Pardigon, N., Reynes, J.-M., Pettinelli, F., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030263 · Cited by 1,222 · cited 2×
“Increased virulence of CHIKV as a result of evolutionary adaptation during Chikungunya outbreaks has been reported [Schuffenecker et al., 2006; Santhosh et al., 2008].”
BackgroundChikungunya, an epidemic arbovirosis
Pialoux, G., Gaüzère, B.-A., Jauréguiberry, S., & Strobel, M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70107-x · Cited by 1,129 · cited 2×
“4 million cases have been reported [Charell et al., 2007; Mavalankar et al., 2007; Pialoux et al., 2007].”
BackgroundInfluentialIn vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
Keyaerts, E., Vijgen, L., Maes, P., Neyts, J., & Ranst, M. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 649 · cited 2×
“In light of its availability and cost, and the fact that it is well tolerated, chloroquine offers promise as an anti-viral and immunomodulatory agent for the treatment of emerging viral diseases [Keyaerts et al., 2004].”
BackgroundNew insights into the antiviral effects of chloroquine
Savarino, A., Di Trani, L., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570 · cited 4×
“and the use of chloroquine as a therapeutic for HIV-1 infection is currently being evaluated in clinical trials [Savarino et al., 2006].”
BackgroundMethodInfluentialCharacterization of Reemerging Chikungunya Virus
Sourisseau, M., Schilte, C., Casartelli, N., Trouillet, C., Guivel-Benhassine, F., Rudnicka, D., Sol-Foulon, N., Roux, K. L., Prevost, M.-C., Fsihi, H., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030089 · Cited by 509 · cited 2×
“It has been reported that a low endosomal pH is also required for CHIKV entry into cells [Sourisseau et al., 2007].”
BackgroundChikungunya Outbreaks — The Globalization of Vectorborne Diseases
Charrel, R. N., de Lamballerie, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078013 · Cited by 459
The Arboviruses: Epidemiology and Ecology
Monath, T. P. (2019) · CRC Press eBooks · doi:10.1201/9780429289200 · Cited by 412
Dye Uptake Methods for Assessing Viral Cytopathogenicity and their Application to Interferon Assays
Finter, N. B. (1969) · Journal of General Virology · doi:10.1099/0022-1317-5-3-419 · Cited by 388 · cited 2×
“The number of viable cells was quantified 36 hpi by neutral red dye uptake assay [Finter, 1969] .”
MethodThe clathrin endocytic pathway in viral infection
DeTulleo, L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4585 · Cited by 281 · cited 2×
“…Alphaviruses like Sindbis virus (SINV) and Semilink Forest virus (SFV), conformational changes in the viral envelope glycoprotein and subsequent viral fusion are mediated by clathrinmediated endocytosis by the target cell and the low pH of the endosomal compartment [DeTulleo and Kirchhausen, 1998].”
BackgroundChikungunya epidemic in India: a major public-health disaster
Mavalankar, D., Shastri, P., & Raman, P. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70091-9 · Cited by 191 · cited 2×
“4 million cases have been reported [Charell et al., 2007; Mavalankar et al., 2007; Pialoux et al., 2007].”
BackgroundInfluentialInhibition of Human Immunodeficiency Virus Infectivity by Chloroquine
Tsai, W.-P., Nara, P. L., Kung, H., & Oroszlan, S. I. (1990) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1990.6.481 · Cited by 160 · cited 2×
“Anti-viral effects of chloroquine against SARS-CoV, HIV type 1 and hepatitis B virus have also been reported [Kouroumalis and Koskinas, 1986; Tsai et al., 1990; Vincent et al., 2005], and the use of chloroquine as a therapeutic for HIV-1 infection is currently being evaluated in clinical trials…”
BackgroundEffects of lysosomotropic weak bases on infection of BHK-21 cells by Sindbis virus
Cassell, S., Edwards, J., & Brown, D. T. (1984) · Journal of Virology · doi:10.1128/jvi.52.3.857-864.1984 · Cited by 96 · cited 3×
“infection, for example, endosome-mediated virus entry, and has no effect during later stages of infection [Cassell et al., 1984].”
BackgroundInfluentialDash, P. K., Parida, M., Santhosh, S. R., Verma, S. K., Tripathi, N. K., Ambuj, S., Saxena, P., Gupta, N., Chaudhary, M., Babu, J. P., et al. (2007) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2006.0648 · Cited by 84 · cited 1×
“The CHIVK isolate DRDE-06, which belongs to the ECS African genotype, was used in the present study [Dash et al., 2007].”
MethodSelf-citationDash, P. K., Parida, M., Santhosh, S. R., Verma, S. K., Tripathi, N. K., Ambuj, S., Saxena, P., Gupta, N., Chaudhary, M., Babu, J. P., et al. (2007) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2007.7272 · Cited by 80
Self-citationRNA interference mediated inhibition of Chikungunya virus replication in mammalian cells
Dash, P. K., Tiwari, M., Santhosh, S. R., Parida, M., & Rao, P. V. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.040 · Cited by 75 · cited 2×
“inhibition of CHIKV replication has achieved limited success [Dash et al., 2008].”
BackgroundSelf-citation
Cited by
Devaux, C. A., Rolain, J.-M., Colson, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105938 · Cited by 1,099
Chikungunya: a re-emerging virus
Burt, F. J., Rolph, M. S., Rulli, N. E., Mahalingam, S., & Heise, M. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60281-x · Cited by 638
Delang, L., Segura Guerrero, N., Tas, A., Quérat, G., Pastorino, B., Froeyen, M., Dallmeier, K., Jochmans, D., Herdewijn, P., Bello, F., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku209 · Cited by 232
Hydroxychloroquine in rheumatic autoimmune disorders and beyond
Nirk, E. L., Reggiori, F., & Mauthe, M. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012476 · Cited by 192
“…et al, 1998; Keyaerts et al, 2004; Vincent et al, 2005; Blanchard et al, 2006; De Clercq, 2006; Eng et al, 2006; Di Trani et al, 2007; Sourisseau et al, 2007; Khan et al, 2010; Ashfaq et al, 2011; Boonyasuppayakorn et al, 2014; Farias et al, 2015; Delvecchio et al, 2016; Shiryaev et al, 2017).”
BackgroundSilva, J. V. J., Ludwig-Begall, L. F., Oliveira-Filho, E. F. D., Oliveira, R. A. S., Durães-Carvalho, R., Lopes, T. R. R., Silva, D. E. A., & Gil, L. H. V. G. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.09.003 · Cited by 170
Metadata
- Authors
- Khan, M., Santhosh, S. R., Tiwari, M., Lakshmana Rao, P. V., & Parida, M.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2010-03-24
- Volume
- 82
- Issue
- 5
- Pages
- 817-824
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W2060823949
- Cited by
- 196
- References
- 18
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.